Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD

• Autore principale: D’Urzo A (Autore)
• Natura: Libro
• Pubblicazione: Dove Medical Press, 2013-08-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Anthony D'UrzoDepartment of Family and Community Medicine, University of Toronto, Toronto, ON, CanadaAbstract: Progressive airflow limitation is a hallmark feature of chronic obstructive pulmonary disease (COPD) that ultimately leads to breathlessness, impaired quality of life, and reduced e...